TY - JOUR
T1 - Apoptotic death of lymphocytes in murine acquired immunodeficiency syndrome
T2 - Involvement of Fas‐Fas ligand interaction
AU - Kanagawa, Osami
AU - Vaupel, Barbara A.
AU - Korsmeyer, Stanley J.
AU - Russell, John H.
PY - 1995/9
Y1 - 1995/9
N2 - Murine acquired immunodeficiency syndrome (MAIDS) is caused by a defective murine leukemia virus. The disease is characterized by abnormal lymphoproliferation, impaired T and B cell function and aberrant regulation of cytokines. Both T and B lymphocytes show activated phenotypes, but undergo apoptotic death with characteristic DNA fragmentation. These results indicate the presence of a continuous activation death pathway of the lymphocytes in MAIDS. Overexpression of the bcl‐2 transgene in lymphocytes showed no effect on the apoptotic cell death or on the development of the disease. In contrast, mice carrying mutations in either Fas or Fas ligand exhibited accelerated progression of the disease upon infection with MAIDS virus. These results suggest the involvement of Fas‐Fas ligand system in the pathogenesis of MAIDS.
AB - Murine acquired immunodeficiency syndrome (MAIDS) is caused by a defective murine leukemia virus. The disease is characterized by abnormal lymphoproliferation, impaired T and B cell function and aberrant regulation of cytokines. Both T and B lymphocytes show activated phenotypes, but undergo apoptotic death with characteristic DNA fragmentation. These results indicate the presence of a continuous activation death pathway of the lymphocytes in MAIDS. Overexpression of the bcl‐2 transgene in lymphocytes showed no effect on the apoptotic cell death or on the development of the disease. In contrast, mice carrying mutations in either Fas or Fas ligand exhibited accelerated progression of the disease upon infection with MAIDS virus. These results suggest the involvement of Fas‐Fas ligand system in the pathogenesis of MAIDS.
KW - Apoptosis
KW - Fas
KW - Fas ligand
KW - Murine acquired immunodeficiency syndrome
UR - http://www.scopus.com/inward/record.url?scp=0029082284&partnerID=8YFLogxK
U2 - 10.1002/eji.1830250902
DO - 10.1002/eji.1830250902
M3 - Article
C2 - 7589105
AN - SCOPUS:0029082284
SN - 0014-2980
VL - 25
SP - 2421
EP - 2427
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 9
ER -